ProCE Banner Activity

Stroke Prevention in NVAF: Optimizing Screening and Management

Text Module
Significant challenges remain to improving stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) despite recent advances in therapeutic management options. Often asymptomatic and increasing in prevalence, the consequences of undiagnosed and untreated atrial fibrillation are dire—leaving patients at increased risk for ischemic stroke. This case-based activity addresses the challenges of improving patient care for NVAF, focusing on implementation of guideline-directed screening approaches in a real-world setting, individualized stroke risk stratification, and holistic therapeutic management strategies using thromboprophylaxis with oral anticoagulants for stroke prevention.

Released: July 08, 2019

Expiration: July 06, 2020

No longer available for credit.

Share

Faculty

Gerald V. Naccarelli

Gerald V. Naccarelli, MD

Bernard Trabin Chair in Cardiology
Professor of Medicine
Chief
Division of Cardiology
Pennsylvania State University College of Medicine
The Milton S. Hershey Medical Center
Hershey, Pennsylvania

Provided by

Provided by Continuing Education Alliance
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Pfizer Alliance

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Screen patients at risk for NVAF according to current guidelines and using diagnostic tools
  • Integrate direct oral anticoagulants into the treatment of patients at stroke risk according to available guidelines and evidence

Faculty Disclosure

Primary Author

Gerald V. Naccarelli, MD

Bernard Trabin Chair in Cardiology
Professor of Medicine
Chief
Division of Cardiology
Pennsylvania State University College of Medicine
The Milton S. Hershey Medical Center
Hershey, Pennsylvania

Dr Nacarelli: consultant: Acesion, Janssen, Milestone, Omeicos; grant/research support: Janssen.